Central Line-Associated Bloodstream Infection QI Project
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.
Eligibility criteria
Qualifiers
Not hospice patient class
Active central line for at least 24 hours
Disqualifiers
No active central line
Central line present for less than 24 hours
Trial design
Treatments tested in this trial
- Not listed
Trial groups
30 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov